• About us
• Contact

Advertisement

Product › Details

finance

Record changed: 2025-04-06

Advertisement

More documents for finance

• [1] Veraxa Biotech AG. (4/23/25). "Press Release: Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies". Zürich & Brooklyn, NY....
• [2] Glycomine, Inc.. (4/16/25). "Press Release: Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial for PMM2-CDG". San Carlos, CA....
• [3] Meribel Pharma Solutions. (4/15/25). "Press Release: Meribel Pharma Solutions Launches with Big Ambitions to Elevate Pharma Services to New Heights"....
• [4] Immunic, Inc.. (4/10/25). "Press Release: Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments". New York, NY....
• [5] Immunic, Inc.. (4/9/25). "Press Release: Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments". New York, NY....
• [6] Medigene AG. (4/7/25). "Press Release: Medigene AG Files Application for the Opening of Insolvency Proceedings". Planegg....
• [7] Angelini Ventures S.p.A.. (4/7/25). "Press Release: Angelini Ventures Appoints Seasoned Life Sciences Investor, Dr. Regina Hodits, as Managing Director". Rome....
• [8] Neurona Therapeutics. (4/3/25). "Press Release: Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline". South San Francisco, CA....
• [9] Novadip Biosciences S.A.. (4/2/25). "Press Release: Novadip Appoints Soumya Chandramouli as Chief Financial Officer". Mont-Saint-Guibert....
• [10] AIRNA Corporation. (4/1/25). "Press Release: AIRNA Raises Oversubscribed $155 Million Series B Financing to Fund Phase 1/2 Clinical Trial for Alpha-1 Antitrypsin Deficiency and Future Pipeline". Cambridge, MA & Tübingen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.